The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.
Now, the nasal spray can be used on its own ... The participants were required to start a new antidepressant while taking Spravato. This was partly a safety precaution to ensure that the ...
The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.
The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.